Prolonged neonatal opioid exposure has been associated with: antinociceptive tolerance, long-term neurodevelopmental delay, cognitive, and motor impairment. Morphine has also been shown to induce apoptotic cell death in vitro studies, but its in vivo effect in developing rat brain is unknown. Thus, we hypothesized that prolongued morphine administration in neonatal rats in a model of antinociceptive tolerance and dependence is associated with increased neuroapoptosis. We analyzed neonatal rats from the following groups (1) naïve group (n = 6); (2) control group (normal saline (NS), n = 5), and (3) morphine group (n = 8). Morphine sulfate or equal volume of NS was injected subcutaneously twice daily for 6½ days starting on postnatal day (PD) 1. Development of antinociceptive tolerance was previously confirmed by Hot Plate test on the 7th day. Evidence of neuronal and glial apoptosis was determined by cleaved caspase-3 immunofluorescence combined with specific markers. At PD7, morphine administration after 6½ days significantly increased the density of apoptotic cells in the cortex and amygdala, but not in the hippocampus, hypothalamus, or periaqueductal gray. Apoptotic cells exhibited morphology analogous to neurons. Irrespective of the treatment, only a very few individual microglia but not astrocytes were caspase-3 positive. In summary, repeated morphine administration in neonatal rats (PD1-7) is associated with increased supraspinal apoptosis in distinct anatomical regions known to be important for sensory (cortex) and emotional memory processing (amygdala). Brain regions important for learning (hippocampus), and autonomic and nociceptive processing (hypothalamus and periaqueductal gray) were not affected. Lack of widespread glial apoptosis or robust glial activation following repeated morphine administration suggests that glia might not be affected by chronic morphine at this early age. Future studies should investigate long-term behavioral sequelae of demonstrated enhanced apoptosis associated with prolonged morphine administration in a neonatal rat model.
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Introduction
Although the impact of chronic maternal opioid exposure on in utero brain development has been widely studied both in humans (Besunder and Blumer, 1990; Hunt et al., 2008; Konijnenberg and Melinder, 2011; McGlone et al., 2009; Walhovd et al., 2009 ) and animals (Che et al., 2005; He et al., 2010; Nasiraei-Moghadam et al., 2010 , 2012 Sadraie et al., 2008; Seatriz and Hammer, 1993;  Abbreviations: GFAP, glial fibrillary acidic protein; Iba-1, ionized calcium binding adaptor molecule 1; ip, intraperitoneal; NeuN, neuronal nuclear antigen; nNOS, neuronal nitric oxide synthase (NOS1); NS, normal saline; PB, phosphate buffer; PD, postnatal day; sc, subcutaneous. Slamberova et al., 2005), less in known about the long-term effects of morphine when administered postnatally. Human infants are exposed to opioids every day worldwide in the context of perioperative and procedural pain management. Even in the absence of pain, critically ill neonates and children receive prolonged opioids for sedation to reduce anxiety, agitation, stress responses, and to facilitate ventilation (Anand, 2001; Berde and Sethna, 2002; Chambliss and Anand, 1997) . Such treatment is associated with markedly high incidence (35-57%) of analgesic tolerance and opioid dependence (Anand et al., 2010; Fonsmark et al., 1999; Katz et al., 1994) , as well as long-term neurodevelopmental delay, neurocognitive and motor impairments (de Graaf et al., 2011; McGlone et al., 2009) . A recent pilot study at 5-year follow up (Ferguson et al., 2012) reported differences in head circumference, abnormal choice response latencies, and diminished social interactions between morphine and placebo treated preterm neonates. All together, these reports are suggestive of significant alterations in neural pathways resulting
